INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
SEC FORM 4/Grant or awardVerified data

Abu-Absi Susan reported AURA

Chief Operating Officer · Aura Biosciences, Inc. · Common Stock

Side
A
Value
—
Shares
134.5K
Price
—
Executed
Sep 1, 2026
Disclosed
Sep 1, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Sep 1 executedSep 1, 2026 disclosed

AURA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · AURA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    EA
    Elazzouzi AmySVP, Finance & PAO
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    23.5K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    EA
    Elazzouzi AmySVP, Finance & PAO
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    46.5K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    13
    HJ
    Hopkins Janet JillChief Medical Officer
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    58.9K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    PJ
    Person JulieChief People Officer
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    107.6K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    PJ
    Person JulieChief People Officer
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    212.4K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    AS
    Abu-Absi SusanChief Operating Officer
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    265.5K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    HJ
    Hopkins Janet JillChief Medical Officer
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    116.2K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KE
    Kratz EricaChief Reg. & Quality Officer
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    100.9K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KE
    Kratz EricaChief Reg. & Quality Officer
    AURAAura Biosciences, Inc.
    Grant or award
    		A—
    199.1K sh
    		Sep 1, 2026Sep 1, 2026
    traded Sep 1, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002148701-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Sep 1, 2026
    Published
    Sep 1, 2026
    Ingested by INSIDER
    Nov 5, 02:19 UTC
    Last re-read
    Nov 5, 02:19 UTC

    Extracted facts

    Filer
    Abu-Absi Susan
    Role
    Chief Operating Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Aura Biosciences, Inc.
    Ticker
    AURA
    Shares
    134.5K
    Price per share
    $0
    Execution date (reported)
    Sep 1, 2026
    Owned after transaction
    134.5K shares
    Days from execution to publication
    0

    What this establishes

    Abu-Absi Susan filed this Form 4 reporting a grant or award of AURA on Sep 1, 2026. It became public on Sep 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Operating Officer
    Abu-Absi Susancik:0002148701
    Issuer
    Aura Biosciences, Inc.cik:0001501796

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.

    Data sources
    SEC FORM 43h ago
    HOUSE PTR3h ago
    SEC 13F3h ago
    ROBINHOOD CHAIN3h ago